Profil
Clifford Baron worked as the Chief Operating Officer at CollabRx, Inc. and as the Chief Operating Officer & Vice President at Rennova Health, Inc. He received an undergraduate degree from the University of Washington and a doctorate degree from the University of California, Berkeley.
Anciens postes connus de Clifford Baron
| Sociétés | Poste | Fin |
|---|---|---|
| RENNOVA HEALTH, INC. | Directeur des opérations | 02/11/2015 |
CollabRx, Inc.
 CollabRx, Inc. Data Processing ServicesTechnology Services CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA. | Directeur des opérations | - |
Formation de Clifford Baron
| University of Washington | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RENNOVA HEALTH, INC. | Technology Services |
| Entreprise privées | 1 |
|---|---|
CollabRx, Inc.
CollabRx, Inc. Data Processing ServicesTechnology Services CollabRx, Inc. is a data analytics company. It offers cloud-based systems, which provides clinically relevant interpretive knowledge to institutions, physicians, researchers and patients for genomics-based medicine in cancer and other diseases to inform health care decision-making. Its CollabRx Therapy Finders product provides information to physicians and patients for rapidly determining which medical tests, therapies, and clinical trials may be considered in cancer treatment planning with a specific emphasis on the tumor genetic profile. The company was founded by Jeff Shrager in December 1989 and is headquartered in San Francisco, CA. | Technology Services |
